Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Neuroendocrine Control of Macrophage Development and Function.

Jurberg AD, Cotta-de-Almeida V, Temerozo JR, Savino W, Bou-Habib DC, Riederer I.

Front Immunol. 2018 Jun 25;9:1440. doi: 10.3389/fimmu.2018.01440. eCollection 2018. Review.

2.

The Neuropeptides Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Control HIV-1 Infection in Macrophages Through Activation of Protein Kinases A and C.

Temerozo JR, de Azevedo SSD, Insuela DBR, Vieira RC, Ferreira PLC, Carvalho VF, Bello G, Bou-Habib DC.

Front Immunol. 2018 Jun 12;9:1336. doi: 10.3389/fimmu.2018.01336. eCollection 2018.

3.

HTLV-1-infected thymic epithelial cells convey the virus to CD4+ T lymphocytes.

Carvalho Barros LR, Linhares-Lacerda L, Moreira-Ramos K, Ribeiro-Alves M, Machado Motta MC, Bou-Habib DC, Savino W.

Immunobiology. 2017 Dec;222(12):1053-1063. doi: 10.1016/j.imbio.2017.08.001. Epub 2017 Aug 14.

PMID:
28888743
4.

Protective effect of gedunin on TLR-mediated inflammation by modulation of inflammasome activation and cytokine production: Evidence of a multitarget compound.

Borges PV, Moret KH, Raghavendra NM, Maramaldo Costa TE, Monteiro AP, Carneiro AB, Pacheco P, Temerozo JR, Bou-Habib DC, das Graças Henriques M, Penido C.

Pharmacol Res. 2017 Jan;115:65-77. doi: 10.1016/j.phrs.2016.09.015. Epub 2016 Sep 15.

PMID:
27641928
5.

HIV-1 Tat protein enhances the intracellular growth of Leishmania amazonensis via the ds-RNA induced protein PKR.

Vivarini Áde C, Pereira Rde M, Barreto-de-Souza V, Temerozo JR, Soares DC, Saraiva EM, Saliba AM, Bou-Habib DC, Lopes UG.

Sci Rep. 2015 Nov 26;5:16777. doi: 10.1038/srep16777.

6.

HAM/TSP-derived HTLV-1-infected T cell lines promote morphological and functional changes in human astrocytes cell lines: possible role in the enhanced T cells recruitment into Central Nervous System.

Gudo ES, Silva-Barbosa SD, Linhares-Lacerda L, Ribeiro-Alves M, Real SC, Bou-Habib DC, Savino W.

Virol J. 2015 Oct 12;12:165. doi: 10.1186/s12985-015-0398-x.

7.

HIV infection and antiretroviral therapy lead to unfolded protein response activation.

Borsa M, Ferreira PL, Petry A, Ferreira LG, Camargo MM, Bou-Habib DC, Pinto AR.

Virol J. 2015 May 15;12:77. doi: 10.1186/s12985-015-0298-0.

8.

Inhibition of ecto-ATPase activities impairs HIV-1 infection of macrophages.

Schachter J, Delgado KV, Barreto-de-Souza V, Bou-Habib DC, Persechini PM, Meyer-Fernandes JR.

Immunobiology. 2015 May;220(5):589-96. doi: 10.1016/j.imbio.2014.12.004. Epub 2014 Dec 20.

PMID:
25577295
9.

IL-27 enhances Leishmania amazonensis infection via ds-RNA dependent kinase (PKR) and IL-10 signaling.

Barreto-de-Souza V, Ferreira PL, Vivarini Ade C, Calegari-Silva T, Soares DC, Regis EG, Pereira RM, Silva AM, Saraiva EM, Lopes UG, Bou-Habib DC.

Immunobiology. 2015 Apr;220(4):437-44. doi: 10.1016/j.imbio.2014.11.006. Epub 2014 Nov 15.

PMID:
25466588
10.

2´,3´-Dialdehyde of ATP, ADP, and adenosine inhibit HIV-1 reverse transcriptase and HIV-1 replication.

Schachter J, Valadao AL, Aguiar RS, Barreto-de-Souza V, Rossi AD, Arantes PR, Verli H, Quintana PG, Heise N, Tanuri A, Bou-Habib DC, Persechini PM.

Curr HIV Res. 2014;12(5):347-58.

PMID:
25174839
11.

HIV-1 and its gp120 inhibits the influenza A(H1N1)pdm09 life cycle in an IFITM3-dependent fashion.

Mesquita M, Fintelman-Rodrigues N, Sacramento CQ, Abrantes JL, Costa E, Temerozo JR, Siqueira MM, Bou-Habib DC, Souza TM.

PLoS One. 2014 Jun 30;9(6):e101056. doi: 10.1371/journal.pone.0101056. eCollection 2014.

12.

The effects of neurotrophins and the neuropeptides VIP and PACAP on HIV-1 infection: histories with opposite ends.

Souza TM, Temerozo JR, Giestal-de-Araujo E, Bou-Habib DC.

Neuroimmunomodulation. 2014;21(5):268-82. doi: 10.1159/000357434. Epub 2014 Mar 1. Review.

13.

Activation of Toll-like receptor 2 increases macrophage resistance to HIV-1 infection.

Victoria S, Temerozo JR, Gobbo L, Pimenta-Inada HK, Bou-Habib DC.

Immunobiology. 2013 Dec;218(12):1529-36. doi: 10.1016/j.imbio.2013.06.006. Epub 2013 Jun 21.

PMID:
23891328
14.

Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP.

Temerozo JR, Joaquim R, Regis EG, Savino W, Bou-Habib DC.

PLoS One. 2013 Jun 20;8(6):e67701. doi: 10.1371/journal.pone.0067701. Print 2013.

15.

Dolabelladienetriol, a compound from Dictyota pfaffii algae, inhibits the infection by Leishmania amazonensis.

Soares DC, Calegari-Silva TC, Lopes UG, Teixeira VL, de Palmer Paixão IC, Cirne-Santos C, Bou-Habib DC, Saraiva EM.

PLoS Negl Trop Dis. 2012;6(9):e1787. doi: 10.1371/journal.pntd.0001787. Epub 2012 Sep 6.

16.

The nerve growth factor reduces APOBEC3G synthesis and enhances HIV-1 transcription and replication in human primary macrophages.

Souza TM, Rodrigues DQ, Passaes CP, Barreto-de-Souza V, Aguiar RS, Temerozo JR, Morgado MG, Fontes CF, Araujo EG, Bou-Habib DC.

Blood. 2011 Mar 10;117(10):2944-52. doi: 10.1182/blood-2010-05-287193. Epub 2011 Jan 7.

17.

Elevated levels of macrophage migration inhibitory factor (MIF) in the plasma of HIV-1-infected patients and in HIV-1-infected cell cultures: a relevant role on viral replication.

Regis EG, Barreto-de-Souza V, Morgado MG, Bozza MT, Leng L, Bucala R, Bou-Habib DC.

Virology. 2010 Mar 30;399(1):31-38. doi: 10.1016/j.virol.2009.12.018. Epub 2010 Jan 20.

18.

Novel role for the double-stranded RNA-activated protein kinase PKR: modulation of macrophage infection by the protozoan parasite Leishmania.

Pereira RM, Teixeira KL, Barreto-de-Souza V, Calegari-Silva TC, De-Melo LD, Soares DC, Bou-Habib DC, Silva AM, Saraiva EM, Lopes UG.

FASEB J. 2010 Feb;24(2):617-26. doi: 10.1096/fj.09-140053. Epub 2009 Oct 7.

PMID:
19812373
19.

Synthesis, antiviral activity and molecular modeling of oxoquinoline derivatives.

Santos Fda C, Abreu P, Castro HC, Paixão IC, Cirne-Santos CC, Giongo V, Barbosa JE, Simonetti BR, Garrido V, Bou-Habib DC, Silva Dde O, Batalha PN, Temerozo JR, Souza TM, Nogueira CM, Cunha AC, Rodrigues CR, Ferreira VF, de Souza MC.

Bioorg Med Chem. 2009 Aug 1;17(15):5476-81. doi: 10.1016/j.bmc.2009.06.037. Epub 2009 Jun 24.

PMID:
19581097
20.

Characterization of HIV-1 enzyme reverse transcriptase inhibition by the compound 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid through kinetic and in silico studies.

Souza TM, Rodrigues DQ, Ferreira VF, Marques IP, da Costa Santos F, Cunha AC, de Souza MC, de Palmer Paixão Frugulhetti IC, Bou-Habib DC, Fontes CF.

Curr HIV Res. 2009 May;7(3):327-35.

PMID:
19442130
21.

The compound 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid inhibits HIV-1 replication by targeting the enzyme reverse transcriptase.

Souza TM, Cirne-Santos CC, Rodrigues DQ, Abreu CM, Tanuri A, Ferreira VF, Marques IP, de Souza MC, Fontes CF, Frugulhetti IC, Bou-Habib DC.

Curr HIV Res. 2008 May;6(3):209-17.

PMID:
18473784
22.

HIV-1 infection and HIV-1 Tat protein permit the survival and replication of a non-pathogenic trypanosomatid in macrophages through TGF-beta1 production.

Barreto-de-Souza V, Xavier Medeiros T, Machado Motta MC, Bou-Habib DC, Saraiva EM.

Microbes Infect. 2008 May;10(6):642-9. doi: 10.1016/j.micinf.2008.02.014. Epub 2008 Mar 10.

PMID:
18457978
23.

The dolabellane diterpene Dolabelladienetriol is a typical noncompetitive inhibitor of HIV-1 reverse transcriptase enzyme.

Cirne-Santos CC, Souza TM, Teixeira VL, Fontes CF, Rebello MA, Castello-Branco LR, Abreu CM, Tanuri A, Frugulhetti IC, Bou-Habib DC.

Antiviral Res. 2008 Jan;77(1):64-71. Epub 2007 Sep 6.

PMID:
17888523
24.

Genetic and biologic characterization of HIV type 1 subtype C isolates from south Brazil.

Monteiro JP, Ferraro GA, Oliveira T, Goldani LZ, Kashima S, Alcantara LC, Morgado MG, Bou-Habib DC, Galvão-Castro B.

AIDS Res Hum Retroviruses. 2007 Jan;23(1):135-43.

PMID:
17263643
25.

Increased Leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E2 synthesis.

Barreto-de-Souza V, Pacheco GJ, Silva AR, Castro-Faria-Neto HC, Bozza PT, Saraiva EM, Bou-Habib DC.

J Infect Dis. 2006 Sep 15;194(6):846-54. Epub 2006 Aug 10.

PMID:
16941353
26.

Interaction of macrophages with apoptotic cells enhances HIV Type 1 replication through PGE2, PAF, and vitronectin receptor.

Lima RG, Moreira L, Paes-Leme J, Barreto-de-Souza V, Castro-Faria-Neto HC, Bozza PT, Bou-Habib DC.

AIDS Res Hum Retroviruses. 2006 Aug;22(8):763-9.

PMID:
16910832
27.

Inhibition of HIV-1 replication in human primary cells by a dolabellane diterpene isolated from the marine algae Dictyota pfaffii.

Cirne-Santos CC, Teixeira VL, Castello-Branco LR, Frugulhetti IC, Bou-Habib DC.

Planta Med. 2006 Mar;72(4):295-9.

PMID:
16557468
28.

Report of the Fifth Brazilian Symposium on HIV/AIDS Research. Rio de Janeiro, RJ, Brazil. November 23-26, 2003.

Bongertz V, Bou-Habib DC, Castello-Branco LR, Morgado MG.

Mem Inst Oswaldo Cruz. 2005 Feb;100(1):67-71. Epub 2005 Apr 12. No abstract available.

29.

Anti-HIV-1 activity of the Iboga alkaloid congener 18-methoxycoronaridine.

Silva EM, Cirne-Santos CC, Frugulhetti IC, Galvão-Castro B, Saraiva EM, Kuehne ME, Bou-Habib DC.

Planta Med. 2004 Sep;70(9):808-12.

PMID:
15386189
30.

Inhibition of HIV-1 infection by monoclonal antibodies to carbohydrates of Schistosoma mansoni.

Mello MA, Mascarenhas RE, Ferraro GA, Harn D, Galvão-Castro M, Bou-Habib DC.

Med Microbiol Immunol. 2005 Jan;194(1-2):61-5.

PMID:
14634805
31.

Prevalence of the CCR5Delta32 mutation in Brazilian populations and cell susceptibility to HIV-1 infection.

Grimaldi R, Shindo N, Acosta AX, Dourado I, Brites C, de Melo Carvalho O, Brito I, Bou-Habib DC, Galvão-Castro B.

Hum Genet. 2002 Jul;111(1):102-4. Epub 2002 Jun 13.

PMID:
12136242
32.

The replication of human immunodeficiency virus type 1 in macrophages is enhanced after phagocytosis of apoptotic cells.

Lima RG, Van Weyenbergh J, Saraiva EM, Barral-Netto M, Galvão-Castro B, Bou-Habib DC.

J Infect Dis. 2002 Jun 1;185(11):1561-6. Epub 2002 May 17.

PMID:
12023761
33.

Biological characterization and chemokine receptor usage of HIV type 1 isolates prevalent in Brazil.

Ferraro GA, Mello MA, Sutmöller F, Van Weyenbergh J, Shindo N, Galvão-Castro B, Bou-Habib DC; Brazilian Network for HIV Isolation and Characterization.

AIDS Res Hum Retroviruses. 2001 Sep 1;17(13):1241-7.

PMID:
11559423
34.

Antileishmanial activity of an indole alkaloid from Peschiera australis.

Delorenzi JC, Attias M, Gattass CR, Andrade M, Rezende C, da Cunha Pinto A, Henriques AT, Bou-Habib DC, Saraiva EM.

Antimicrob Agents Chemother. 2001 May;45(5):1349-54.

35.

HIV-1 diversity in Brazil: genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. Brazilian Network for HIV Isolation and Characterization.

Bongertz V, Bou-Habib DC, Brígido LF, Caseiro M, Chequer PJ, Couto-Fernandez JC, Ferreira PC, Galvão-Castro B, Greco D, Guimarães ML, Linhares de Carvalho MI, Morgado MG, Oliveira CA, Osmanov S, Ramos CA, Rossini M, Sabino E, Tanuri A, Ueda M.

J Acquir Immune Defic Syndr. 2000 Feb 1;23(2):184-93.

PMID:
10737434
36.

CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV-1 strains in a T-cell line.

Oravecz T, Roderiquez G, Koffi J, Wang J, Ditto M, Bou-Habib DC, Lusso P, Norcross MA.

Nat Med. 1995 Sep;1(9):919-26.

PMID:
7585218
37.
38.

Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization.

Bou-Habib DC, Roderiquez G, Oravecz T, Berman PW, Lusso P, Norcross MA.

J Virol. 1994 Sep;68(9):6006-13.

39.

Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines.

Patel M, Yanagishita M, Roderiquez G, Bou-Habib DC, Oravecz T, Hascall VC, Norcross MA.

AIDS Res Hum Retroviruses. 1993 Feb;9(2):167-74.

PMID:
8096145

Supplemental Content

Loading ...
Support Center